论文部分内容阅读
Enalapril是一种新的长效口服药,它是无疏基血管紧张素转换酶抑制剂,它比Captopril强4～9倍。本文用enalapril和双氢克尿噻(DCT)对39例原发性高血压患者进行治疗并观察了肾功能和血
Enalapril is a new long-acting oral drug that is a non-sparse angiotensin-converting enzyme inhibitor that is 4 to 9 times more potent than Captopril. In this paper, enalapril and hydrochlorothiazide (DCT) 39 patients with essential hypertension were treated and observed renal function and blood